Stemgent Revenue and Competitors
Estimated Revenue & Valuation
- Stemgent's estimated annual revenue is currently $1.2M per year.
- Stemgent's estimated revenue per employee is $77,500
- Stemgent's total funding is $58.4M.
Employee Data
- Stemgent has 16 Employees.
- Stemgent grew their employee count by -6% last year.
Stemgent's People
| Name | Title | Email/Phone |
|---|
Stemgent Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.3M | 2 | -60% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $7.4M | 48 | 0% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is Stemgent?
We're here for one purpose: to help you advance stem cell science. We do that by providing proprietary reagents and tools developed and proven for reproducibility by some of the world's leading stem cell scientists. But we're not just improving on the reagents available for stem cell research.
keywords:Biotechnology
$58.4M
Total Funding
16
Number of Employees
$1.2M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Stemgent News
Race Chemical Shanghai Race Chemical Co., Ltd. Santa Cruz Biotechnology, Inc. STEMCELL Technologies Inc. Stemgent, Inc. Tocris Bioscience.
Cayman Chemical Co. Abcam Plc. Alfa Chemistry. Stemgent, Inc. Glentham Life Sciences. STEMCELL Technologies Inc.
Stemgent; Cayman Chemical; Santa Cruz Biotechnology; Stemcell Technologies; Alfa Chemistry; Anward; Race Chemical; Glentham Life Sciences; Abmole Bioscience...
Other Companies in Beltsville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.5M | 17 | 13% | N/A |
#2 | N/A | 17 | -23% | N/A |
#3 | $2M | 20 | 5% | N/A |
#4 | $2M | 20 | 11% | N/A |
#5 | $3.2M | 21 | -12% | N/A |